Skip to main content
. 2011 Nov;134(3):305–313. doi: 10.1111/j.1365-2567.2011.03490.x

Figure 2.

Figure 2

Expansion ability of different subsets to the global (a) Gag- and (b) Nef-specific CD8+ T responses, according to the absence/presence of protective class I human leucocyte antigen (HLA)-B* alleles in typical progressors (TP), long-term non-progressors (LTNPs) and subjects on HAART for at least 1 year and maintaining undetectable viral load (HP).